Synaptogenix Stock Buy Hold or Sell Recommendation
| SNPX Stock | USD 4.56 0.01 0.22% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Synaptogenix is 'Strong Sell'. Macroaxis provides Synaptogenix buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding SNPX positions. The advice algorithm takes into account all of Synaptogenix's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Synaptogenix's buy or sell advice are summarized below:
Real Value 6.86 | Target Price 14 | Hype Value 5.3 | Market Value 4.56 | Naive Value 4.64 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Synaptogenix given historical horizon and risk tolerance towards Synaptogenix. When Macroaxis issues a 'buy' or 'sell' recommendation for Synaptogenix, the advice is generated through an automated system that utilizes algorithms and statistical models.
Synaptogenix |
Execute Synaptogenix Buy or Sell Advice
The Synaptogenix recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Synaptogenix. Macroaxis does not own or have any residual interests in Synaptogenix or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Synaptogenix's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Weak | Details | |
Volatility | Unstable | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | High | Details | |
Economic Sensitivity | Barely shadows the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Hold | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Synaptogenix Trading Alerts and Improvement Suggestions
| Synaptogenix had very high historical volatility over the last 90 days | |
| Synaptogenix has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (6.04 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Synaptogenix currently holds about 28.75 M in cash with (5.17 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.2. | |
| Synaptogenix has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Were Hopeful That Synaptogenix Will Use Its Cash Wisely - Yahoo Movies Canada |
Synaptogenix Returns Distribution Density
The distribution of Synaptogenix's historical returns is an attempt to chart the uncertainty of Synaptogenix's future price movements. The chart of the probability distribution of Synaptogenix daily returns describes the distribution of returns around its average expected value. We use Synaptogenix price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Synaptogenix returns is essential to provide solid investment advice for Synaptogenix.
| Mean Return | -0.09 | Value At Risk | -13.27 | Potential Upside | 12.22 | Standard Deviation | 8.18 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Synaptogenix historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Synaptogenix Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Synaptogenix is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Synaptogenix backward and forwards among themselves. Synaptogenix's institutional investor refers to the entity that pools money to purchase Synaptogenix's securities or originates loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Hayek Kallen Investment Management | 2023-12-31 | 17.5 K | Elevated Capital Advisors, Llc | 2023-12-31 | 15.9 K | Advisor Group Holdings, Inc. | 2023-12-31 | 3.4 K | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 2.3 K | Orion Capital Management Llc | 2023-12-31 | 2 K | Ubs Group Ag | 2023-12-31 | 1.8 K | Blackrock Inc | 2023-12-31 | 942 | Acadian Asset Management Llc | 2023-12-31 | 591 | Tower Research Capital Llc | 2023-12-31 | 386 | Renaissance Technologies Corp | 2023-12-31 | 540.9 K | Geode Capital Management, Llc | 2023-12-31 | 154.5 K |
Synaptogenix Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Synaptogenix or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Synaptogenix's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Synaptogenix stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | -0.1 | |
β | Beta against NYSE Composite | 0.08 | |
σ | Overall volatility | 7.95 | |
Ir | Information ratio | -0.02 |
Synaptogenix Volatility Alert
Synaptogenix is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Synaptogenix's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Synaptogenix's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Synaptogenix Fundamentals Vs Peers
Comparing Synaptogenix's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Synaptogenix's direct or indirect competition across all of the common fundamentals between Synaptogenix and the related equities. This way, we can detect undervalued stocks with similar characteristics as Synaptogenix or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Synaptogenix's fundamental indicators could also be used in its relative valuation, which is a method of valuing Synaptogenix by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Synaptogenix to competition |
| Fundamentals | Synaptogenix | Peer Average |
| Return On Equity | -0.2 | -0.31 |
| Return On Asset | -0.15 | -0.14 |
| Current Valuation | (23.9 M) | 16.62 B |
| Shares Outstanding | 1.09 M | 571.82 M |
| Shares Owned By Insiders | 2.43 % | 10.09 % |
| Shares Owned By Institutions | 3.92 % | 39.21 % |
| Number Of Shares Shorted | 298.54 K | 4.71 M |
| Price To Book | 0.21 X | 9.51 X |
| EBITDA | (8.31 M) | 3.9 B |
| Net Income | (6.04 M) | 570.98 M |
| Cash And Equivalents | 28.75 M | 2.7 B |
| Cash Per Share | 4.20 X | 5.01 X |
| Current Ratio | 47.22 X | 2.16 X |
| Book Value Per Share | 25.27 X | 1.93 K |
| Cash Flow From Operations | (5.17 M) | 971.22 M |
| Short Ratio | 0.67 X | 4.00 X |
| Earnings Per Share | (29.50) X | 3.12 X |
| Target Price | 14.0 | |
| Number Of Employees | 5 | 18.84 K |
| Beta | 1.58 | -0.15 |
| Market Capitalization | 4.96 M | 19.03 B |
| Total Asset | 31.11 M | 29.47 B |
| Retained Earnings | (33.61 M) | 9.33 B |
| Working Capital | 26.26 M | 1.48 B |
| Net Asset | 31.11 M |
Note: Acquisition by Bernstein Bruce of 800 shares of Synaptogenix at 5. subject to Rule 16b-3 [view details]
Synaptogenix Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Synaptogenix . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Daily Balance Of Power | (9,223,372,036,855) | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 4.56 | |||
| Day Typical Price | 4.56 | |||
| Price Action Indicator | (0.01) | |||
| Period Momentum Indicator | (0.01) | |||
| Relative Strength Index | 57.14 |
About Synaptogenix Buy or Sell Advice
When is the right time to buy or sell Synaptogenix? Buying financial instruments such as Synaptogenix Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.| 2021 | 2022 | 2023 | 2024 (projected) | Other Current Liabilities | 698.4K | 652.6K | 3.8M | 4.0M | Total Assets | 35.5M | 38.6M | 31.1M | 28.6M |
Use Investing Ideas to Build Portfolios
In addition to having Synaptogenix in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Shipping Containers Thematic Idea Now
Shipping Containers
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Shipping Containers theme has 15 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Shipping Containers Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Synaptogenix Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Synaptogenix Stock please use our How to Invest in Synaptogenix guide.You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Complementary Tools for Synaptogenix Stock analysis
When running Synaptogenix's price analysis, check to measure Synaptogenix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Synaptogenix is operating at the current time. Most of Synaptogenix's value examination focuses on studying past and present price action to predict the probability of Synaptogenix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Synaptogenix's price. Additionally, you may evaluate how the addition of Synaptogenix to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |
Is Synaptogenix's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Synaptogenix. If investors know Synaptogenix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Synaptogenix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (29.50) | Return On Assets (0.15) | Return On Equity (0.20) |
The market value of Synaptogenix is measured differently than its book value, which is the value of Synaptogenix that is recorded on the company's balance sheet. Investors also form their own opinion of Synaptogenix's value that differs from its market value or its book value, called intrinsic value, which is Synaptogenix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Synaptogenix's market value can be influenced by many factors that don't directly affect Synaptogenix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Synaptogenix's value and its price as these two are different measures arrived at by different means. Investors typically determine if Synaptogenix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Synaptogenix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.